Reduced adipogenic gene expression in fibroblasts from a patient with type 2 congenital generalized lipodystrophy-Reference-Cited by-同舟云学术

Reduced adipogenic gene expression in fibroblasts from a patient with type 2 congenital generalized lipodystrophy

Published:2010-06-08 Issue:10 Volume:27 Page:1178-1187
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:

Author:

Victoria B.,Cabezas-Agrícola J. M.,González-Méndez B.,Lattanzi G.,Del Coco R.,Loidi L.,Barreiro F.,Calvo C.,Lado-Abeal J.,Araújo-Vilar D.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-5491.2010.03052.x/fullpdf

Reference49 articles.

1. Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy;Agarwal;J Clin Endocrinol Metab,2003

2. General lipodystrophy, congenital and acquired (lipoatrophy);Seip;Acta Paediatr,1996

3. Studies of insulin resistance in congenital generalized lipodystrophy;Sovik;Acta Paediatr,1996

4. Mutations in Gng3lg and AGPAT2 in Berardinelli-Seip congenital lipodystrophy and Brunzell syndrome: phenotype variability suggests important modifier effects;Fu;J Clin Endocrinol Metab,2004

5. Leptin levels, β-cell function, and insulin sensitivity in families with congenital and acquired generalized lipoatropic diabetes;Pardini;J Clin Endocrinol Metab,1998

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A murine model of BSCL2-associated Celia's encephalopathy;Neurobiology of Disease;2023-10

2. Role of Seipin in Human Diseases and Experimental Animal Models;Biomolecules;2022-06-17

3. Hereditary severe insulin resistance syndrome: Pathogenesis, pathophysiology, and clinical management;Genes & Diseases;2022-04

4. Successful long-term use of pioglitazone in Berardinelli–Seip lipodystrophy-associated diabetes;Endocrinology, Diabetes & Metabolism Case Reports;2021-04-01

5. La vie sans tissu adipeux : les lipodystrophies généralisées congénitales ; causes, physiopathologie et prise en charge thérapeutique;Médecine des Maladies Métaboliques;2021-03